| 摘要 |
A method of reducing the serum level in a mammal of any one more cholesterol, low density lipoprotein (LDL) cholesterol relative to high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, very low density lipoprotein (VLDL) cholesterol, apolipoprotein B, and triglycerides by the ingestion of a composition containing beta-casein A2. A dietary supplement formed by the addition of beta-casein to a food or drink for human consumption where the beta-casein is comprised of at least 95% beta- casein A2, preferably solely beta-casein A2. |
